Humira (adalimumab) is a prescription biologic medication widely used to manage a range of chronic inflammatory and autoimmune diseases. It works by reducing inflammation in the body caused by overactive immune responses. By targeting specific immune pathways, Humira offers relief from symptoms and slows disease progression.

• Rheumatoid Arthritis (RA): Humira is FDA-approved for moderate to severe RA in adults, helping reduce joint pain, swelling, and long-term damage when used regularly.

• Crohn’s Disease: It is indicated for moderate to severe Crohn’s disease in adults and children over six years old, helping reduce intestinal inflammation and maintain remission.

• Psoriatic Arthritis: Humira improves joint symptoms and helps manage skin lesions in patients suffering from psoriatic arthritis, offering dual benefits.

• Plaque Psoriasis: For patients with moderate to severe plaque psoriasis, Humira reduces the size, redness, and scaling of skin lesions by targeting inflammatory proteins.

• Ulcerative Colitis: Humira is approved for treating ulcerative colitis, helping reduce flare-ups and improve colon health by suppressing immune overactivity.

• Ankylosing Spondylitis: It provides relief for adults with this type of spinal arthritis by decreasing stiffness and preserving spinal mobility.

• Hidradenitis Suppurativa: For moderate to severe cases, Humira can reduce the number and severity of nodules and abscesses.

• Juvenile Idiopathic Arthritis (JIA): Approved for children aged 2 years and above, Humira helps control inflammation and joint symptoms in various forms of JIA.

Humira is classified as a TNF-alpha inhibitor. It targets and blocks the activity of a protein called tumor necrosis factor-alpha (TNF-α), which plays a key role in causing inflammation in several autoimmune diseases. By neutralizing this protein, Humira reduces abnormal immune responses and prevents damage to healthy tissues.

• Targets TNF-alpha: TNF-α is a cytokine responsible for systemic inflammation. Humira binds to TNF-α and blocks its interaction with cell surface receptors, preventing the cascade of inflammatory responses.

• Modulates immune system: Unlike broad immunosuppressants, Humira selectively targets inflammatory pathways, which reduces symptoms while preserving essential immune function.

• Prevents joint and tissue damage: By limiting the immune attack on joints and organs, Humira slows disease progression and minimizes long-term complications.

• Reduces symptom severity: Patients typically experience less pain, stiffness, swelling, and fatigue once Humira takes effect.

• Supports remission maintenance: Especially in conditions like Crohn’s disease and ulcerative colitis, Humira helps maintain symptom-free periods over the long term.

• Improves skin conditions: In plaque psoriasis, Humira targets the source of inflammation, leading to visible skin improvement within a few weeks.

• Delivers consistent effect: With regular dosing, patients maintain stable blood levels of the medication, leading to sustained symptom control.

Humira is not a steroid. It is classified as a biologic immunomodulator or targeted immunosuppressant. While it does suppress specific parts of the immune system, it is fundamentally different from corticosteroids in both composition and mechanism.

• Biologic medication: Humira is produced using recombinant DNA technology and is designed to mimic natural antibodies, making it a biologic rather than a synthetic drug.

• Not a corticosteroid: Unlike steroids such as prednisone, Humira does not interfere with hormonal systems or produce the same side effects associated with long-term steroid use.

• Selective immune targeting: It specifically blocks TNF-alpha, a protein involved in chronic inflammation, rather than suppressing the entire immune system.

• Fewer systemic side effects: Because of its targeted nature, Humira is less likely to cause widespread immune suppression or hormone-related side effects.

• Alternative to long-term steroid use: In many treatment plans, Humira is prescribed to reduce or eliminate the need for long-term steroid therapy.

• Slower onset, longer duration: Humira usually takes a few weeks to work but offers long-term control, unlike steroids which act rapidly but may not be sustainable.

• Better for chronic use: For long-term autoimmune disease management, biologics like Humira are often preferred due to lower long-term risks compared to steroids.

Yes, Humira is specifically designed for self-administration at home. The medication is provided in easy-to-use pre-filled pens or syringes. With basic training and adherence to instructions, most patients are able to confidently self-inject without medical assistance.

• User-friendly delivery: Humira comes in an auto-injector pen and a pre-filled syringe. The auto-injector requires minimal preparation and is ideal for first-time users.

• Initial training recommended: Patients are encouraged to receive guidance from a healthcare professional during the first injection to build confidence and ensure proper technique.

• Flexible administration sites: Injections can be given in the thigh or abdomen, avoiding areas with visible veins or bruises.

• Visual and audible cues: The Humira pen gives a click sound once the injection is complete, reducing uncertainty during administration.

• Convenient for travel and daily life: Self-injection allows patients to manage their condition without frequent clinic visits, improving lifestyle flexibility.

• Safe storage: The pen or syringe must be kept refrigerated, but can be stored at room temperature (up to 25°C) for short periods if needed during travel.

• Instructional materials provided: Humira includes detailed leaflets and sometimes videos to assist with self-injection training at home.

The frequency of Humira dosing depends on the condition being treated, the patient’s response, and the severity of symptoms. The standard adult dosing for most indications is every other week, but certain cases may require weekly injections. Always follow your healthcare provider’s instructions.

• Every other week: This is the most common dosing schedule for adults with RA, psoriatic arthritis, and ankylosing spondylitis.

• Weekly dosing: In cases of severe rheumatoid arthritis or when patients do not respond well to biweekly dosing, weekly injections may be prescribed.

• Crohn’s disease and ulcerative colitis: Initial dosing typically involves a loading dose followed by regular maintenance doses every two weeks.

• Plaque psoriasis: Often begins with an initial dose, followed by maintenance dosing every two weeks.

• Juvenile idiopathic arthritis: Pediatric dosing varies based on weight and age and is generally administered every other week.

• Consistency is key: Maintaining a strict schedule is crucial for the medication to remain effective over time.

• Missed dose guidance: If a dose is missed, it should be taken as soon as remembered unless it is very close to the next scheduled dose.

Missing a dose of Humira may disrupt the consistency of your treatment, but there are clear guidelines for managing missed injections. It’s important not to panic—most situations can be corrected by returning to your usual schedule as soon as possible.

• Take the missed dose as soon as possible: If you remember within a few days, administer the missed injection immediately and then continue with your regular schedule.

• Skip if close to next dose: If the missed dose is too close to your next scheduled injection, skip it and continue with the next one on time—never double-dose to make up.

• Maintain consistent timing: Try to administer Humira at the same time on the scheduled day to establish a routine and reduce the chance of forgetting.

• Set reminders: Using smartphone alerts, injection calendars, or apps can help ensure you never miss a dose again.

• Contact your healthcare provider if unsure: If you’re confused about what to do after missing a dose, it’s always best to reach out for professional guidance.

• Record the incident: Note the date and time you missed the dose to help track any impact on your symptoms.

• Monitor symptoms: If you notice any flare-ups or return of symptoms after missing a dose, inform your doctor, as dosage adjustment may be needed.

Yes, while Humira is generally well tolerated, it may cause serious side effects in some individuals. These side effects are uncommon but require immediate medical attention. Understanding them can help you act quickly if they arise.

• Increased risk of infections: Humira can lower your immune response, increasing your risk of serious infections such as tuberculosis (TB), pneumonia, and fungal infections.

• Injection site reactions: Redness, swelling, itching, or bruising may occur where the injection is administered, usually resolving on their own.

• Allergic reactions: Some individuals may experience rashes, itching, swelling, dizziness, or difficulty breathing—these require emergency care.

• Nervous system problems: Rarely, Humira has been linked to demyelinating diseases like multiple sclerosis or seizures. Unusual numbness, vision issues, or weakness should be reported immediately.

• Heart failure: Humira may worsen congestive heart failure. If you experience shortness of breath, swelling, or fatigue, seek medical advice.

• Blood disorders: Symptoms such as persistent fever, bruising, or pale skin may suggest changes in blood cell counts and need prompt evaluation.

• Liver problems: Signs include yellowing of the skin or eyes (jaundice), dark urine, and elevated liver enzymes on blood tests.

• Increased risk of certain cancers: Though rare, long-term use has been associated with lymphoma and other malignancies, particularly in young adults.

Yes, Humira is designed to modulate immune activity, which by nature lowers certain immune responses. While this helps control chronic inflammation, it also means that your immune defenses can be compromised to a limited extent.

• Targeted immune suppression: Humira selectively blocks TNF-alpha, which plays a central role in immune signaling, especially during inflammation.

• Increased infection risk: You may be more susceptible to respiratory infections, urinary tract infections, and skin infections while on Humira.

• Vaccination precautions: Live vaccines (like MMR or yellow fever) are not recommended during Humira treatment because of the risk of infection from the vaccine itself.

• Routine screening: Before starting Humira, patients are usually screened for latent tuberculosis and hepatitis B to reduce risks.

• Long-term monitoring: Regular blood tests may be advised to monitor white blood cell levels and overall immune function.

• Avoid sick contacts: During flu season or outbreaks, take extra care to avoid close contact with sick individuals.

• Consult your doctor for immune-related changes: If you notice frequent infections, slow healing, or unusual fatigue, your immune system may be reacting to the drug.

Yes, Humira must be kept refrigerated at all times during storage and shipping. As a biologic medication, it is sensitive to heat and freezing temperatures, which can degrade its effectiveness. At NovaScript Pharmacy, we prioritize strict cold-chain packaging procedures to maintain the product’s integrity.

• Cold chain logistics: We use temperature-controlled packaging, including insulated containers and cold packs, to keep the medication between 2°C and 8°C (36°F to 46°F).

• Real-time monitoring: Some shipments may include temperature indicators that show if the product has been exposed to out-of-range conditions.

• No freezing allowed: Freezing can permanently damage the protein structure of adalimumab, making the medication ineffective.

• Express delivery: We ship Humira using the fastest available method (usually overnight) to reduce the risk of temperature deviation.

• Tamper-proof containers: Each shipment is sealed and packed securely to prevent tampering or environmental exposure.

• Return policy covers spoilage: If your product arrives warm, frozen, or damaged, we will replace it free of charge under our 30-day guarantee.

• Instructions included: We provide handling and storage instructions with every order to ensure you maintain proper conditions after delivery.

Humira can be kept at room temperature (up to 25°C or 77°F) for a maximum of 14 days, but it must be used or discarded within that timeframe. Exceeding this period—or exposing the medication to heat—can render it ineffective.

• 14-day window: If you remove Humira from refrigeration, it must be used within 14 days. After that, discard it even if it appears unchanged.

• Do not re-refrigerate: Once taken out of the fridge, you should not return Humira to cold storage. Temperature cycling can compromise its stability.

• Keep away from direct heat: Do not store Humira near stoves, windows, heaters, or in cars where temperature fluctuations are common.

• Use travel coolers when needed: If you’re transporting Humira, especially on long trips, insulated travel bags or portable refrigerators are highly recommended.

• Label the date: When you take a dose out of refrigeration, write the date on the package so you can track the 14-day usage window.

• Visual check before use: If the medication appears cloudy, discolored, or contains particles, do not use it—even if within the time window.

• Discard responsibly: Expired or heat-exposed Humira should be safely discarded as medical waste. Do not flush or throw it in regular trash.

Yes, you can travel with Humira, but special precautions must be taken to maintain its temperature stability and ensure legal compliance across borders. Since Humira is a temperature-sensitive biologic, it must be handled with care during transport to prevent loss of potency.

• Use insulated travel coolers: A portable cooler or thermal bag with cold packs is essential for keeping Humira between 2°C and 8°C while on the move.

• Check airline policies: Most airlines allow passengers to carry medications in their hand luggage. Be sure to declare Humira during security checks, especially if bringing ice packs or syringes.

• Carry a prescription or doctor’s note (optional): Although we don’t require a prescription for ordering, having documentation can help if questioned by airport or customs officials.

• Avoid checked luggage: Checked baggage is subject to extreme temperatures. Always keep Humira in your carry-on bag where you can monitor its condition.

• Plan for storage at your destination: Ensure that your hotel, Airbnb, or accommodation has a working refrigerator to store Humira safely.

• Track the time out of refrigeration: If traveling for more than 14 days without access to refrigeration, plan to restock or time your injections accordingly.

• Use single-use pens for convenience: Pre-filled pens are easier to manage and dispose of when traveling, reducing the need for sharps containers.

The safety of Humira during pregnancy has been the subject of ongoing research. While some studies suggest that it may be safe for use in certain trimesters, it should only be used under the supervision of a healthcare provider. Each case must be individually evaluated.

• Pregnancy Category B (FDA): Animal studies have not demonstrated fetal harm, but well-controlled studies in pregnant women are lacking.

• Use in high-risk pregnancies: Humira may be continued in women with severe autoimmune diseases if the benefits outweigh the risks.

• Placental transfer in the third trimester: Humira can cross the placenta, particularly in the last trimester, potentially affecting the baby’s immune system.

• Avoid live vaccines for newborns: If Humira was used during pregnancy, especially late-stage, live vaccines (e.g., rotavirus) should be delayed for the infant’s safety.

• Breastfeeding considerations: Humira has been detected in small amounts in breast milk, but studies suggest it’s unlikely to harm the baby due to poor oral absorption.

• Doctor consultation is essential: Pregnant or breastfeeding patients must consult their physician before starting, continuing, or discontinuing Humira.

• Pregnancy exposure registry: Patients can voluntarily enroll in a pregnancy registry to contribute to ongoing research on biologics in pregnancy.

While Humira does not directly interact with alcohol, moderate alcohol consumption should be approached with caution when undergoing treatment. The main concern lies in the combined impact on the immune system and liver, especially if other medications are used concurrently.

• No direct contraindication: There is no official warning against alcohol use with Humira, but patients are encouraged to use moderation.

• Immune suppression overlap: Alcohol can weaken immune function. Combined with Humira’s immunosuppressive action, this may increase the risk of infections.

• Liver strain: If you are taking additional medications such as methotrexate—which is often used with Humira—drinking alcohol can significantly increase liver toxicity risks.

• Avoid binge drinking: High levels of alcohol consumption can lead to inflammation and interfere with the therapeutic effects of Humira.

• Monitor for unusual symptoms: Symptoms like fatigue, jaundice, or digestive issues after drinking may indicate liver problems and should be evaluated immediately.

• Consult your doctor if on multiple medications: Combining Humira with drugs that are processed by the liver may require limiting alcohol more strictly.

• Stay hydrated and informed: If you do choose to drink occasionally, do so responsibly and always prioritize your health condition over convenience.

Humira is a biologic product that must not be frozen. If it freezes during shipping, it may lose its effectiveness, making it unsafe to use. At NovaScript Pharmacy, we take extreme precautions to prevent freezing during transit, but we also have policies in place in case it occurs.

• Do not use frozen Humira: If you suspect or confirm that your Humira has been frozen, do not inject it. Frozen biologics are considered compromised.

• Inspect the product upon arrival: Check for any visible signs of freezing such as crystallization, clumping, or cloudiness. The solution should be clear and colorless.

• Use temperature indicators: Some shipments may include color-based indicators that alert you to possible temperature breaches.

• Report it immediately: Contact our support team right away if you believe the product was exposed to freezing temperatures during delivery.

• Covered under our guarantee: Frozen or damaged shipments are fully covered under our 30-day refund or replacement policy.

• Dispose of safely: If instructed not to use a compromised dose, discard it according to local medical waste guidelines or return it if requested.

• Re-shipment at no cost: We prioritize customer safety, and any proven temperature-compromised order will be replaced immediately at no extra charge.

Humira is the original, FDA-approved brand name for adalimumab, whereas biosimilars are highly similar copies that are developed after the original patent expires. While biosimilars offer similar safety and efficacy, there are key differences in branding, regulation, and patient experience.

• Original biologic: Humira was the first adalimumab product approved and is the reference standard for biosimilars.

• Same mechanism of action: Biosimilars like Amjevita, Cyltezo, and Hyrimoz are designed to have no clinically meaningful differences from Humira in terms of safety and effectiveness.

• Manufacturing differences: Biologics are made from living cells, so no two versions (even biosimilars) are chemically identical, which can affect tolerability or immune response in some patients.

• Price and availability: Biosimilars are often more affordable than the original product but may have limited availability in certain markets.

• Interchangeability status: Not all biosimilars are interchangeable. Only FDA-designated interchangeable biosimilars can be substituted without prescriber approval.

• Brand loyalty and response: Some patients may respond better or more consistently to the original Humira, especially after long-term use.

• Insurance or provider preference: In traditional systems, biosimilars are sometimes preferred by insurers or national healthcare systems due to cost savings.